DNA RNA and Cells

03 Sep 2009 NOXXON Is Awarded Research and Development Grant for First-in-Human Clinical Trial with Spiegelmer® NOX-A12
01 Sep 2009 Gene Signal and Collaborators Publish GS-101 Clinical Data Suggesting Safe and Effective Inhibition of Abnormal Ophthalmic Blood Vessel Growth
31 Aug 2009 Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barcelona, Spain
27 Aug 2009 Geron Comments on FDA Hold on Spinal Cord Injury Trial
27 Aug 2009 Lakewood-Amedex Inc. to Develop Broad Spectrum Influenza Drug to Include H1N1 and H5N1 Type A Strains
25 Aug 2009 AVI BioPharma Phase 1 Proof of Concept and Safety Data for AVI-4658 in Duchenne Muscular Dystrophy Featured in Lancet Neurology
24 Aug 2009 Shire Builds Competitive Position of its HGT Business through Research Collaboration with Santaris Pharma A/S on LNA Drug Platform
21 Aug 2009 STEMEDICA REQUESTS PRE-IND MEETING WITH FDA
19 Aug 2009 Gentium Reports Top Line Results from the Phase III Treatment Trial of Defibrotide for Severe Veno-Occlusive Disease
18 Aug 2009 Geron's IND for Spinal Cord Injury Placed on Hold
17 Aug 2009 Mesoblast Limited (ASX:MSB) Gains US FDA Clearance For Phase 2 Trial Of NeoFuse In Minimally Invasive Lumbar Spinal Fusion Surgery
17 Aug 2009 New Data on ATL1101 Activity in Tumour Cells Further Supports Drug’s Potential in Prostate Cancer
11 Aug 2009 Gene Signal Announces Publication of Phase I Data Highlighting Safety of GS-101 for Diseases of the Eye
10 Aug 2009 Compassionate Use Patients in Spain Treated With Adult Stem Cell Therapy Demonstrate Jaw Bone Regeneration Enabling Dental Implants
10 Aug 2009 ReNeuron announces publication of pre-clinical data with its ReN003 programme for diseases of the retin
07 Aug 2009 Opexa Announces Stem Cell Agreement with Leading Global Pharmaceutical Company
06 Aug 2009 ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program
06 Aug 2009 Alnylam and Tekmira Participate in New Research Collaboration
05 Aug 2009 Aldagen Reaches Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3 Trial of ALD-301 for Critical Limb Ischemia
05 Aug 2009 PROPRIETARY TECHNOLOGY IN WORLD-FIRST ALLOGENEIC STEM CELL TRIAL FOR TREATMENT OF END-STAGE HEART FAILURE IN PATIENTS SUPPORTED BY MECHANICAL HEART ASSIST DEVICES
03 Aug 2009 MDRNA, Inc. Reports Positive In Vivo Data Demonstrating That Its UsiRNAs Are Highly Potent Against Metabolic and Oncology Targets
30 Jul 2009 ReNeuron receives UK ethics committee Favourable Opinion for stroke clinical trial
27 Jul 2009 RXi Pharmaceuticals Acquires Exclusive License to Proprietary, Potentially Paradigm-Changing RNAi Delivery Technology from Advirna LLC
27 Jul 2009 Quark Pharmaceuticals Announces Data Indicating Potential Utility of QPI-1007 for Treatment of Glaucoma
27 Jul 2009 MOLOGEN AG extends clinical study to include another dosing group

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top